Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 Gains 51.88%
Thu, Jul 11, 2024 at 07:22 PM
Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ) rocketted at $1.08, representing a gain of 51.9%. On Thu, Jul 11, 2024, BDRX:NASDAQ touched a New 2-Week High of $1.08. The stock got featured on our News Catalysts scanner on Thu, Jul 11, 2024 at 10:31 AM in the 'BIOTECH' category. From Thu, Jun 27, 2024, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Thu, Jul 11, 2024 at $1.65 with a volume of 63M+.
About Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ)
Midatech Pharma PLC is a part of the healthcare sector. As a pharmaceutical company, it focuses on commercializing and developing products in oncology and other therapeutic areas.
Top 10 Gainers:
- Locafy Limited (LCFY:NASDAQ), 158.47%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 85.57%
- Cyngn Inc. (CYN:NASDAQ), 85.1%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 75%
- NexImmune Inc. (NEXI:NASDAQ), 68.67%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 51.88%
- Methode Electronics, Inc. (MEI:NYSE), 45.76%
- Bite Acquisition Corp. (BITE:NYSEMKT), 43.68%
- Bite Acquisition Corp. (BITE:NYSE), 43.68%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 38.04%